Małopolskie Badania Kliniczne Sp Z o.o.

The research at Małopolskie Badania Kliniczne Sp Z o.o. emphasizes immune‑mediated conditions, seeking to improve therapies for patients with Sjögren’s syndrome. Trials focus on assessing long‑term safety and overall effectiveness of emerging biologic agents that modulate the immune response.

• Long‑term safety evaluation
• Development of novel biologic treatments
• Patient‑reported outcome measures

Collaboration with local rheumatology specialists supports the advancement of new options for autoimmune disease management.

At this Cracow site, investigators concentrate on inflammatory joint disorders, including Active Psoriatic Arthritis and Axial Spondyloarthritis. The purpose of the studies is to lessen pain, improve spinal mobility, and slow disease progression through innovative therapeutic approaches.

• Targeted small‑molecule efficacy
• MRI‑based monitoring of inflammation
• Functional and quality‑of‑life outcomes

A multidisciplinary team works to deliver treatments that restore daily function for individuals living with chronic joint disease.

The centre also investigates conditions affecting skin and connective tissue, such as Psoriatic Arthritis. Research aims to evaluate new therapies that can control skin manifestations while protecting joint health, offering a comprehensive approach for patients.

• Combined dermatologic and rheumatologic endpoints
• Safety profiling of novel agents
• Impact on overall quality of life

With two seasoned investigators, the site contributes valuable data to global efforts to manage complex connective‑tissue disorders.